Pledge I think maybe even the MSB board at this point of time wish they had partnered the back pain and the heart approach and got them going and near approval now, if not already given hindsight.
BUT apart from wanting a bigger % of the future gains to be retained there are probably other reasons we don't know the full story on due to proprietary and secret knowledge they have that we do not.
The heart hearing has been delayed for many months. Why? Does it have something to do with Dr Perin's work in creating a device for delivery of the cells. What do they know that make this critical before we start? Are they putting off the talks themselves rather than the FDA before this is ready? Will this device merely help % chances of success or will it greatly expand the range of treatments for possible approval?
Whay has the back pain trial been delayed starting for so long. Is the only reason a lack of funding to do so? Have they tried to do a partnership deal but been offered only shockingly bad terms so far only?
Does SI simply have a much longer 'investment time frame' than the average shareholder?
banter and General Discussion, page-7789
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |